Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
about
The G-protein-coupled estrogen receptor GPER in health and diseaseEstrogen receptor alpha interacts with mitochondrial protein HADHB and affects beta-oxidation activityAddressing the soy and breast cancer relationship: review, commentary, and workshop proceedingsCYP19A1 promoter methylation in saliva associated with milestones of pubertal timing in urban girlsDevelopment of a high sensitivity, nested Q-PCR assay for mouse and human aromataseIn vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patientsIn situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer.GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breastPlasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.Hydrophilic interaction chromatography-electrospray ionization tandem mass spectrometric analysis of anastrozole in human plasma and its application to a pharmacokinetic study.Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.The transdermal patches for site-specific delivery of letrozole: a new option for breast cancer therapyProgesterone--promoter or inhibitor of breast cancer.Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.Understanding obesity and endometrial cancer risk: opportunities for preventionEstrone-3-sulphate, a potential novel ligand for targeting breast cancers.Breast ductal lavage for assessment of breast cancer biomarkers.Electron emission and product analysis of estrone: progesterone interactions studied by experiments in vitro.Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial.Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception.Dairy product consumption and the risk of breast cancer.A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges.Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer CellsNipple Aspirate Fluid Hormone Concentrations and Breast Cancer RiskEstrogens in the breast tissue: a systematic review.Measurement of sex steroid hormones in breast adipocytes: methods and implications.HER2 status and disparities in luminal breast cancers.Exogenous and endogenous hormones and breast cancer.Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells.Can breast cancer patients use soyafoods to help reduce risk of CHD?Anticancer steroids: linking natural and semi-synthetic compounds.Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues.Clinical implications of estrone sulfate measurement in laboratory medicine.Dense breast tissue in postmenopausal women is associated with a pro-inflammatory microenvironment in vivoOvercoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.Transport of the soy isoflavone daidzein and its conjugative metabolites by the carriers SOAT, NTCP, OAT4, and OATP2B1.Toremifene use does not alter serum inhibin A and B levels during mid-luteal phase in women with premenstrual mastalgia.Effects of testosterone on cardiomyocyte calcium homeostasis and contractile function in female rats.
P2860
Q27013052-1383791C-DC4C-4DE5-88E6-D672D241351BQ28260956-798F330B-35FF-4CA1-95D1-C92C2952FEB2Q28264426-CD6FD163-F446-475D-B7FA-5CF393B7942BQ29109882-895C55CE-10F0-4E59-BB1F-F82AFE70A5C7Q30440930-C8F90416-14E1-4BB3-AD6E-59932B72832DQ33325668-23D421DD-DBA7-47D4-B645-914B82574346Q33468636-03FB13DE-79E7-4B6E-9C2A-CC1A87459582Q33882180-001CF81A-27FF-4F5A-8AF5-39A1BC43328BQ33891825-54B3F7E0-61C5-405A-84D4-8A6B721FC2BDQ33927689-F61C9E25-99C5-4B98-9879-5C90FC7F90F6Q34158134-3A105ABA-C3E0-4546-AE40-311A1022CB7FQ34280259-FFDAC7B2-F80E-444D-BD02-4C2CB05707A5Q34323606-4E91BC69-A875-49B5-B2AD-5F1B5689B8C9Q34613562-10F0945C-65A9-4746-A7F0-A7548D815336Q34690392-CA301D2D-0F46-4CF1-A7A1-92C1582323ACQ34745098-AB321B41-3D1A-4767-A932-63BD007A2390Q34865963-E75E206C-0783-4F00-8B11-15D9BEB9F3AAQ35094160-E5FE6934-B34C-4807-81A2-10647AA8838AQ35204705-4A785E0F-AABF-461E-BEBC-084CACB37958Q36140716-ED8A5144-69E3-4D1D-9086-91519DF67D4FQ36351148-EB51551A-24B0-45EB-8E91-A17C4EDF48EBQ36507085-FEDA5233-4CE5-473F-B814-5036772A1565Q36545100-B0867096-D97D-4201-9CDD-1DC2317EA272Q36654691-A81553EF-4583-43B6-8DCF-7EB11D31FAAEQ36728342-F70BC690-625F-4ED9-85CC-BD19F15FAF6CQ36840495-C968C47C-89E0-4DD4-8957-0232CEF663FCQ36944544-AAB856CB-6E24-404C-9541-130BCDC47D04Q36969512-87F1D573-BBF3-4053-88F6-A92FDD1A7618Q37008462-2DD53884-4563-400A-9C60-F27CC34D6743Q37439257-BC78C479-0038-4AEC-A93C-B2894D829F2DQ38032972-D11C27DB-986C-4941-8B10-9DF16528FE27Q38059807-761928D5-ABC2-43EE-8F7A-899A37C47E07Q38994657-1E4AE66C-79F8-4B22-A818-669E057391ADQ39037694-34338CF4-D4FA-498D-A5AA-F2CC5B8C96D9Q39181819-FE1792E9-0012-4C11-8090-D732F963A849Q39227889-152ED044-0A24-4AD8-AE8E-C3273A9B17F5Q40348474-DB672E9C-40B0-4B05-99FC-7EADADE4389AQ42703862-27C5A478-FA46-4FB0-B59F-4BD830ECC09AQ43194604-CD7A0C9E-0134-423F-BDEA-94278E425A16Q45908585-91F5135F-64FE-47AB-8802-F45B59EEE9CA
P2860
Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@ast
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@en
type
label
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@ast
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@en
prefLabel
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@ast
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@en
P1476
Breast cancer tissue estrogens ...... e inhibitors and inactivators.
@en
P2093
Jürgen Geisler
P304
P356
10.1016/S0960-0760(03)00364-9
P577
2003-09-01T00:00:00Z